Functional and Morphological Evaluation of Meibomian Glands in the Assessment of Meibomian Gland Dysfunction Subtype and Severity.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
01 2020
Historique:
received: 14 05 2019
revised: 09 09 2019
accepted: 10 09 2019
pubmed: 19 9 2019
medline: 18 4 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

To classify subtypes of meibomian gland dysfunction (MGD) and evaluate the dependency of dry eye signs, symptoms, and parameters on MGD subtype. Cross-sectional study. the right eyes of 447 patients with MGD of various subtypes and 20 healthy volunteers. Patients were divided into 4 subtypes of MGD based on meibum expression, meibum quality, and MG loss on meibography images (meibograde of 0-6). Subtypes were patients with high meibum delivery (hypersecretory and nonobvious MGD) and those with low meibum delivery (hyposecretory and obstructive MGD). Additional clinical tests included tear film break-up time (TFBUT), ocular staining, osmolarity, Schirmer I, blink interval timing and the Ocular Surface Disease Index (OSDI) questionnaire. A total of 78 eyes had hypersecretory MGD; 49 eyes had nonobvious MGD; 66 eyes had hyposecretory MGD; and 254 eyes had obstructive MGD. Increased tear film osmolarity and lower TFBUT were found in the low-delivery groups; hyposecretory (P = 0.006, P = 0.016) and obstructive MGD (P = 0.008, P = 0.006) relative to high-delivery MGD (hypersecretory and nonobvious groups, respectively). Worse ocular symptoms and ocular staining were also found in low-delivery MGD groups than the high delivery MGD groups (P < 0.01 and P < 0.006, respectively). Patients with low-delivery MGD had worse dry eye parameters and ocular symptoms than those with high meibum delivery, indicating the pivotal role of meibum secretion in ocular surface health that should be targeted in MGD therapy. Furthermore, nonobvious MGD cannot be diagnosed using conventional dry eye tests and requires morphologic assessment of meibography images to confirm MG loss.

Identifiants

pubmed: 31526799
pii: S0002-9394(19)30462-3
doi: 10.1016/j.ajo.2019.09.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-167

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Jiaxin Xiao (J)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway. Electronic address: jiaxin1.xiao@gmail.com.

Muhammed Yasin Adil (MY)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

Xiangjun Chen (X)

The Norwegian Dry Eye Clinic, Oslo, Norway; Department of Ophthalmology, Sørlandet Hospital, Arendal, Norway; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Dentistry/Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; Faculty of Health Sciences, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Kongsberg, Norway.

Øygunn A Utheim (ØA)

The Norwegian Dry Eye Clinic, Oslo, Norway.

Sten Ræder (S)

The Norwegian Dry Eye Clinic, Oslo, Norway.

Kim Alexander Tønseth (KA)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway.

Neil S Lagali (NS)

Department of Ophthalmology, Sørlandet Hospital, Arendal, Norway; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

Darlene A Dartt (DA)

Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.

Tor P Utheim (TP)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway; Department of Ophthalmology, Sørlandet Hospital, Arendal, Norway; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Dentistry/Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; Faculty of Health Sciences, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Kongsberg, Norway; Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway; Department of Ophthalmology, Stavanger University Hospital, Stavanger, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH